Bharat Heavy Electricals (BHEL) has informed that the company is in talks with Infrastructure Leasing & Financial Services (IL&FS) for financing its overseas operations.
According to the sources, the two conglomerates will soon enter into a memorandum of understanding (MoU), under which IL&FS will offer the financial packages for BHEL`s international project.
With the view to diversify its business footprints in the international business arena, the public sector unit, is eyeing to make its entry in West Asia, Europe and Africa.
The stock analysts have suggested traders to stay invested in BHEL for long term gains.
Domestic Drug-maker Lupin, acquired 60 percent stakes in South Africa-based Pharma Dynamics. The amount of deal is not disclosed by the company. It is the third acquisition by the company. Earlier in July, Lupin took over the German drug maker Hormosan Pharma and captured most of shares of Generic Health, Australia in August.
RIL, in collaboration with China National Petroleum Corporation (CNPC) and Argentina's Pluspetrol, have bagged rights on Block 155 to extract oil.
The block 155 lies in Southern highland region of Puno, next to the Bolivian border. Since April this yea, it has acquired 90 percent stake in Block 141 in Peru from Pan Andean Resources Plc, In May it acquired 50 percent in block 108 in Peru from Pluspetrol Energy SA, on June 29, it acquired 10% stake in lot 39 in northern Peru from Burlington Resources Inc, .
State-owned oil refiner, Indian Oil Corporation (IOC) would invest around Rs 6,500 crore in order to raise its pipeline network to more than 13,000-KM by March 2012.
Moreover, the company has also decided to finish up its primary gas pipeline by the end of existing year (Dec 2008).
Mr. P.K. Chakraborti, Director-Pipelines, stated that the whole pipeline project will be funded through a debt-equity ratio of 1:1.
“The money will come either from our borrowings or the money from the oil bonds,” Mr. P.K. Chakraborti said.
HCL Technologies intends to complete $2 billion buyouts before 2011. The company is eager to enter in the Europe and Japanese markets. The CEO of HCL, Vineet Nayar said that the company would expand its global presence in the coming years.
He said the company believes in transformational acquisitions besides Intellectual Property (IP) acquisition and geographical acquisition. The company would mainly focus on engineering services, enterprise application services, the newly-launched enterprise transformation services and infrastructure services sectors
Ranbaxy would hire the services of Giuliani Partners to deal with the situation arising, after the banning of some of its products in the US market. It is recalled that the US Food and Drug Administration is not satisfied with the product quality of many of its drugs. It has, earlier banned 31 drugs in the US market. The Indian drug maker Ranbaxy is a major supplier of drugs to the US market.
Pharma Dynamics. The amount of deal is not disclosed by the company. It is the third acquisition by the company. Earlier in July, Lupin took over the German drug maker Hormosan Pharma and captured most of shares of Generic Health, Australia in August. 
Argentina's Pluspetrol, have bagged rights on Block 155 to extract oil.
6,500 crore in order to raise its pipeline network to more than 13,000-KM by March 2012.
is eager to enter in the Europe and Japanese markets. The CEO of HCL, Vineet Nayar said that the company would expand its global presence in the coming years. 
after the banning of some of its products in the US market. It is recalled that the US Food and Drug Administration is not satisfied with the product quality of many of its drugs. It has, earlier banned 31 drugs in the US market. The Indian drug maker Ranbaxy is a major supplier of drugs to the US market. 
